Atlas Trials

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal

Clinical trial NCT02634515 · COMPLETED

Trial details

NCT number
NCT02634515
Sponsor
Julphar Gulf Pharmaceutical Industries
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2014-12-01
Primary completion
2015-02-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.